Tle1 attenuates hepatic ischemia/reperfusion injury by suppressing NOD2/NF-κB signaling.

Wei Chen, Daofeng Zheng, Tong Mou, Junliang Pu, Jiangwen Dai, Zuotian Huang, Yunhai Luo, Yuke Zhang, Zhongjun Wu

Bioscience, biotechnology, and biochemistry 2020 Jun

filter terms:

Liver damage induced by ischemia/reperfusion (I/R) remains a primary issue in multiple hepatic surgeries. Innate immune-mediated inflammatory responses during the reperfusion stage aggravate the injury. Nevertheless, the detailed mechanism of hepatic I/R has not been fully clarified yet. Our research focuses on the role of Transducin-like enhancer of split-1 (Tle1) in the liver I/R injury and the relation between Tle1 and Nucleotide-binding oligomerization domain 2 (NOD2). To answer these questions, we constructed mouse models of I/R and cell models of hypoxia/reoxygenation (H/R). We found decreased Tle1 accompanied by increased NOD2 during reperfusion. Mice pro-injected with Tle1-siRNA emerged aggravated liver dysfunction. Repression of Tle1 had a significant impact on NOD2 and downstream NF-κB signaling in vitro. However, alteration of NOD2 failed to affect the expression of Tle1. To conclude, our study demonstrates that Tle1 shelters the liver from I/R injury through suppression of NOD2-dependent NF-κB activation and subsequent inflammatory responses.

Citation

Wei Chen, Daofeng Zheng, Tong Mou, Junliang Pu, Jiangwen Dai, Zuotian Huang, Yunhai Luo, Yuke Zhang, Zhongjun Wu. Tle1 attenuates hepatic ischemia/reperfusion injury by suppressing NOD2/NF-κB signaling. Bioscience, biotechnology, and biochemistry. 2020 Jun;84(6):1176-1182